Market Size (2017)
2017
—
Vertical: HealthcareBase Year: 201912 Sections
Market Size (2017)
2017
—
Projected (2027)
2027
—
CAGR (2017–2027)
N/A
Key Players
112+
This report covers Chorea Market with forecasts from 2017 to 2027. 112 key companies are profiled.
Chorea Market is a key focus area for market intelligence and strategic research.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnalysis of Chorea Market from 2017 to 2027. Covers North America, Europe, Asia Pacific, Middle East and Africa.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2019
Historical Period
2017 – 2019
Forecast Period
2019 – 2027
Primary Interviews
150+
Historical data (2017–2019) and forecast period (2019–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
See plans for professionals or small and medium businesses.

Analytical insights on Chorea Market covering market dynamics, competitive landscape, and strategic outlook.
Chorea Market represents a significant market opportunity with multiple growth drivers across regions and segments.
The Chorea Market market encompasses 4 key regions and multiple market segments, with the study period spanning 2017 to 2027.
The market is segmented across multiple dimensions, with detailed breakdowns available by component, region, and application type to support strategic planning and investment decisions.
This report profiles 112 key companies operating in the Chorea Market market, covering market positioning, product portfolios, and recent developments.
Leading players include Pfizer Inc., Teva Pharmaceutical Industries Ltd , GLAXOSMITHKLINE PLC, Bausch Health Companies, Inc. , LivaNova PLC, and 107 others.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 112 companies operating in the Chorea Market market, including revenue, employee count, and market positioning where available.
Showing 112 of 112 companies
Pfizer Inc.
Company Headquarters: New York, US Founded: 1849 Workforce: ~83,000 Company Working: Pfizer Inc. (Pfizer) is a leading research-based biopharmaceutical company that applies science and resources to provide innovative treatments that extend and significantly improve lives. Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs), and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies, and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. Furthermore, the company supplies its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East.
LivaNova PLC
Company Headquarters: London, UK Founded: 2015 Workforce: 4,500 employees Company Working: The company is engaged in developing and delivering advanced medical devices for healthcare systems. The company operates in two segments, namely, cardiac surgery and neuromodulation. The company offers VNS Therapy in the brain implants market. The company has a presence in more than 100 countries.
Boston Scientific Corporation
Company Headquarters: Massachusetts, US Founded: 1979 Workforce: ~36,000 Company Working: Boston Scientific Corporation is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In addition, Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. Boston Scientific Corporation's manufacturing facilities are located across Malaysia, the US, and Ireland. Apart from this, it has a presence in countries like Japan, the Netherlands, France, Poland, India, China, Turkey, South Africa, and Singapore.
Teva Pharmaceutical Industries Ltd
Company Headquarters: Petah Tikva, Israel Founded: 1901 Workforce: 43,000+ Company Working: Teva Pharmaceutical Industries Ltd (Teva) is one of the leaders in pharmaceutical industries engaged in developing and providing services in generic medicines. The company has more than 1,800 molecules which are used to create an extensive variety of generic products in almost every therapeutic area. It is specialized in generic medicines, the central nervous system (CNS), brand and specialty medicines, oncology, active pharmaceutical ingredients, respiratory, women's health, and biologics fields. It has more than 35,000 unique products, which is more than any other pharmaceutical company. Teva produced 120 billion tablets and capsules in 2017. Geographically, it operates in regions, namely, North America, Latin America, Europe, Japan, and South Korea. The company operates in more than 60 countries worldwide. It has 26 FDA approved plants, and 31 European Medicines Agency (EMA) approved plants worldwide.
GLAXOSMITHKLINE PLC
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: Brentford, UK Founded: 1999 Workforce: ~95,490 Company Working: GlaxoSmithKline plc is a healthcare company engaged in the research, development, manufacturing, and marketing of pharmaceutical, vaccines, and consumer health-related products. It operates through three major business segments, namely, pharmaceuticals, vaccines, and consumer healthcare. The healthcare segment of the company offers a wide range of products including dairy-based drinks, protein powder, and bars. The company also offers a range of consumer health products including vaccines to prevent infectious diseases.
Aleva Neurotherapeutics
Aleva Neurotherapeutics — Healthcare
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Chorea Market